Table 6.
Clinicopathological patient factors predictive of those undergoing completion axillary lymph node dissection.
| Parameter | Univariable |
Multivariable |
||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P-value | OR | 95% CI | P-value | |
| Age < 75 | 0.982 | 0.359-2.687 | .972 | |||
| IDC subtype | 1.828 | 0.406-8.229 | .432 | |||
| Tumour size > 20 mm | 1.546 | 0.559-4.275 | .401 | |||
| cT2 | 1.629 | 0.619-4.282 | .323 | |||
| Grade 3 | 1.277 | 0.357-4.570 | .707 | |||
| LVI | 0.997 | 0.971-1.024 | .842 | |||
| PgR− | 2.101 | 0.711-6.211 | .179 | |||
| Ki67 > 14% | 0.778 | 0.077-7.886 | .832 | |||
Abbreviations: CI, confidence interval; cT2, clinical tumour stage 2 disease; IDC, invasive ductal carcinoma; LVI, lymphovascular invasion; OR, odds ratio; PgR−, progesterone receptor negativity.